Trials / Completed
CompletedNCT04339881
NOsocomial Dissemination Risk of SARS-Cov2
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,523 (actual)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To date, in France, in the context of the SARS Cov2 pandemic,both the number of affected subjects and the number of severe forms requiring hospital care are increasing. Several nosocomial transmission clusters have already been identified in hospitals (both pediatric and adult) but there is still limited data on the nosocomial spread of SARS-Cov2. This nosocomial transmission affects both patients and caregivers. It is important to understand the spread of the virus within the hospital. This will help to optimize procedures to prevent transmission to caregivers and hospitalizedpatients not infected with SARS Cov2, and more generally this will contribute to control the spread of SARS Cov2 in the community
Detailed description
It is an observational study without any risk. Every participating service will be investigated for 2 consecutive days . * At each staff rotation, an individualsensorwill be provided toall thestaff(caregivers, administrative, students etc…) to be worn duringtheirworking hours. Also a sensor will be placed at each patient's bedside. * In addition, epidemiological data relating to socio-demographic characteristics, profession, protective measures will be collectedfrom hospitalstaff. Also, some data from the 'entrepot des données de santé" regarding individual carepathways in the hospitalwill be extracted. * A map of the unit, specifying the location of each patient will be made.
Conditions
Timeline
- Start date
- 2020-04-17
- Primary completion
- 2020-07-10
- Completion
- 2020-07-12
- First posted
- 2020-04-09
- Last updated
- 2020-11-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04339881. Inclusion in this directory is not an endorsement.